Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheet (Parenthetical)

v3.23.1
Consolidated Balance Sheet (Parenthetical) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Assets    
Federal funds sold and securities borrowed or purchased under agreements to resell measured at fair value $ 163,505 $ 146,999
Trading account assets, pledged as collateral 141,314 115,505
Debt securities:    
Fair Value 525,452 524,267
Loans and leases, measured at fair value 4,397 5,771
Loans held for sale, measured at fair value 1,386 1,115
Other assets, measured at fair value 12,551 9,594
Deposits in U.S. offices:    
Interest bearing, measured at fair value 378 311
Federal funds purchased and securities loans or sold under agreements to repurchase, at fair value 234,338 151,708
Short-term borrowings, measured at fair value 1,805 832
Accrued expenses and other liabilities, measured at fair value 13,659 9,752
Accrued expenses and other liabilities, reserve for unfunded lending commitments 1,437 1,540
Long-term debt, measured at fair value $ 39,413 $ 33,070
Shareholders’ equity    
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock authorized (in shares) 100,000,000 100,000,000
Preferred stock issued (in shares) 4,088,099 4,088,101
Preferred stock outstanding (in shares) 4,088,099 4,088,101
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock authorized (in shares) 12,800,000,000 12,800,000,000
Common stock issued (in shares) 7,972,438,148 7,996,777,943
Common stock outstanding (in shares) 7,972,438,148 7,996,777,943
Short-term borrowings $ 56,564 $ 26,932
Long-term debt 283,873 275,982
Consolidated VIEs    
Shareholders’ equity    
Short-term borrowings 1,339 42
Long-term debt 4,883 4,581
All other liabilities 7 12
Consolidated VIEs | Nonrecourse    
Shareholders’ equity    
Short-term borrowings 22 42
Long-term debt 4,883 4,581
All other liabilities $ 7 $ 13